China Pharma Holdings, Inc.

CPHI · AMEX
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$651-$528-$786-$1,224
Dep. & Amort.$356$321$329$448
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$51$287$186$1,027
Other Non-Cash$109$212$212-$12
Operating Cash Flow-$237$291-$58$238
Investing Activities
PP&E Inv.-$41-$10-$58-$20
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0-$23-$253
Investing Cash Flow-$41-$10-$81-$273
Financing Activities
Debt Repay.-$122-$22-$77$7
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$7$7$0
Financing Cash Flow-$122-$29-$70$7
Forex Effect$42-$40-$5-$64
Net Chg. in Cash-$357$212-$214-$92
Supplemental Information
Beg. Cash$625$413$627$719
End Cash$268$625$413$627
Free Cash Flow-$238$281-$139-$34
China Pharma Holdings, Inc. (CPHI) Financial Statements & Key Stats | AlphaPilot